KFDA considers foreign on-spot inspection

Published: 2008-04-15 07:00:00

Updated: 2008-04-15 07:00:00

The Korea Food and Drug Administration plans to dispatch an on-site inspection team at the end of this month to Merck and Company of the United States as part of expanding its new GMP related inspection to new drugs.

The team, involving officials of the KFDA, will conduct a three-day-long insp...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK